Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
HIV/SIV 包膜跨膜糖蛋白 Gp41 的结构/功能
基本信息
- 批准号:10018385
- 负责人:
- 金额:$ 49.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AntibodiesBindingCD4 AntigensCell membraneCell surfaceCellsComplexCrystallizationDetergentsDissociationDrug ScreeningDrug TargetingEngineeringEpitopesEquilibriumFluorescenceFluorescence Resonance Energy TransferGlycoproteinsHIVHIV Envelope Protein gp120HIV InfectionsLeadLibrariesMediatingMembraneMembrane FusionMembrane PotentialsMethodsMicellesModelingMolecularMolecular ConformationMovementPlayProcessPublishingResolutionRoleSIVSolubilitySpectrum AnalysisStructureSystemTransmembrane DomainViralWorkanalytical ultracentrifugationbasechemokinegp160high throughput screeninginhibitor/antagonistmonomerreceptorsedimentation equilibrium
项目摘要
The central gp41 ectodomain (6-HB) has been studied extensively and is a homotrimer. Therefore, gp41 was considered to remain homotrimeric during all stages of the fusion process. A very recent NMR structure of the gp41 transmembrane domain (TM) alone showed it can form trimers. Our previous NMR and sedimentation equilibrium studies of gp41 (published in Structure in 2014 and mentioned above) indicated, however, a monomer-trimer equilibrium that may have functional importance during the fusion process. We have established by fluorescence resonance energy transfer (FRET) and fluorescence correlation spectroscopy (FCS) that gp41 with the TM embedded in dodecyl phosphatidyl (DPC) micelles undergoes reversible trimeric self-association with dissociation constant in the low micromolar range. This is similar to our previous results using analytical ultracentrifugation. The monomeric potential of the TM, especially at early stages of the fusion process, may play an important mechanistic role during the transition from an elongated gp41 pre-fusion intermediate, bridging viral and host-cell membrane, towards the post-fusion six-helical bundle conformation. A gp41-targeted fusion inhibitor must interfere with this transition and monomeric, partially monomeric or trimeric states all present potential binding epitopes. Based on this premise, gp41 self-association is a valid drug target model and the florescence spectroscopy mentioned above may have potential as a high-throughput assay system that could be used to screen drug libraries. Ongoing work using election spin resonance (ESP) is examining the dynamics of gp41 movement, including the movement of specific domains during the trimerization process.
In other structural studies we engineered a broadly neutralizing gp41 antibody that contains the SARAH domains to increase solubility of the antibody and thus enable high-scale purification of the antibody. The complex of gp41-antibody was crystallized in a solution containing the detergent C8E5 and the hexagonal crystals had weak diffraction that extended to 4 Angstroms. Various methods and approaches are being screened in order to get at higher resolution.
中心gp41外结构域(6-HB)已被广泛研究,是一个同源三聚体。因此,gp41被认为在融合过程的所有阶段都保持同源三聚体。最近对gp41跨膜结构域(TM)的核磁共振分析表明,它可以形成三聚体。然而,我们之前对gp41的核磁共振和沉积平衡研究(发表在2014年的《结构》杂志上,如上所述)表明,在融合过程中,单体-三聚体平衡可能具有重要的功能。通过荧光共振能量转移(FRET)和荧光相关光谱(FCS)证实,gp41与TM嵌入在十二烷基磷脂酰(DPC)胶束中,在低微摩尔范围内发生可逆的三聚体自缔合,解离常数为零。这与我们以前使用分析式超离心的结果相似。TM的单体电位,特别是在融合过程的早期阶段,可能在从一个细长的gp41融合前中间体过渡到融合后的六螺旋束构象的过程中发挥重要的机制作用。gp41融合前中间体连接病毒和宿主细胞膜。靶向gp41的融合抑制剂必须干扰这种转变,并且单体、部分单体或三聚体状态都存在潜在的结合表位。基于这一前提,gp41自结合是一种有效的药物靶点模型,上述荧光光谱技术有可能作为一种高通量分析系统用于筛选药物文库。利用选择性自旋共振(ESP)正在进行的工作是研究gp41运动的动力学,包括在三聚化过程中特定结构域的运动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL T WINGFIELD其他文献
PAUL T WINGFIELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL T WINGFIELD', 18)}}的其他基金
STRUCTURE/FUNCTION OF HIV/SIV ENVELOPE TRANSMEMBRANE GLYCOPROTEIN GP41
HIV/SIV 包膜跨膜糖蛋白 GP41 的结构/功能
- 批准号:
6289042 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure And Assembly Of The Hepatitis B Nucleocapsid
乙型肝炎核衣壳的结构和组装
- 批准号:
6823097 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure/function--HIV/SIV EnvelopeTransmembrane Gp41
结构/功能--HIV/SIV包膜跨膜Gp41
- 批准号:
7007430 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
HIV/SIV 包膜跨膜糖蛋白 Gp41 的结构/功能
- 批准号:
7964901 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
乙型肝炎核衣壳蛋白的结构和组装
- 批准号:
7964902 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
乙型肝炎核衣壳蛋白的结构和组装
- 批准号:
8746496 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure/Function of HIV/SIV Envelope Transmembrane Glycoprotein Gp41
HIV/SIV 包膜跨膜糖蛋白 Gp41 的结构/功能
- 批准号:
8344709 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Structure And Assembly Of The Hepatitis B Nucleocapsid P
乙型肝炎核衣壳 P 的结构和组装
- 批准号:
6680169 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Production Of HIV And HIV Related Proteins For Structura
用于 Structura 的 HIV 和 HIV 相关蛋白的生产
- 批准号:
6680165 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
Production Of HIV And HIV Related Proteins For Structural Studies
用于结构研究的 HIV 和 HIV 相关蛋白的生产
- 批准号:
8559288 - 财政年份:
- 资助金额:
$ 49.91万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Standard Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Discovery Projects
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 49.91万 - 项目类别:
Research Grant














{{item.name}}会员




